BIOPHARMA HOLDING ApS: Financial statements 2023
CVR: 35206086
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIOPHARMA HOLDING ApS (CVR 35206086) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 950,300 and a net result of DKK -20,576,349 compared with DKK -29,721,851 the year before. That is a decrease of 20.4% compared with the year before. Equity in the 2023 report amounted to DKK 107,979,693. The solvency ratio was 93.1%.
- Gross Profit
- DKK 950,300
- Profit/Loss
- DKK -20,576,349
- Equity
- DKK 107,979,693
- Total Assets
- DKK 115,939,375
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 950K | -20.6M | 108M | - |
| 2022 | - | 1.2M | -29.7M | 128.6M | - |
| 2021 | - | 704K | 12M | 158.3M | - |
| 2020 | - | 591K | 1.5M | 146.3M | 1 |
| 2019 | - | 385K | 24.4M | 144.8M | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BIOPHARMA HOLDING ApS has published its annual report for 2022. Gross profit came to DKK 1,193,605, and the net result was DKK -29,721,851.
About BIOPHARMA HOLDING ApS
BIOPHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2013. The company has been dissolved on 17 July 2026. The company was registered under the industry Finansielle holdingselskaber. The company has 1 employee (2017). In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. Equity in the 2024 report amounted to DKK 2,921,095.